Prasterone vaginal - Bayer/Endoceutics
Alternative Names: Dehydroepiandrosterone; DHEA; INTRAROSA; Intrarosa; Intravaginal dehydroepiandrosterone; Intravaginal prasterone; Prasterone vaginal ovule; VaginormLatest Information Update: 05 Nov 2023
At a glance
- Originator Endoceutics
- Developer AMAG Pharmaceuticals; Bayer HealthCare Pharmaceuticals Inc.; Endoceutics; Theramex
- Class Androstenols; Anti-inflammatories; Hormonal replacements; Small molecules
- Mechanism of Action Cell differentiation stimulants; Dehydroepiandrosterone replacements; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atrophic vaginitis; Dyspareunia
- Phase III Decreased libido